Abstract: Methods, systems, and apparatuses to improve the handling of exceptions during the retrieval and processing of health records from various data sources are provided. During the retrieval and processing of health records, exceptions to typical behavior are recorded with context at the data extraction protocol level, at the health record level and at the level of elements with the document. Accordingly, insights may be developed and configurations, rules, or coding changes, based on the detected exceptions may be proposed. In some instances, an operator may be notified about the exceptions such that the operator may act on the insight. In some instances, the processing of extracted records (documents, messages) may be deferred until the operator has made appropriate changes to configuration, rules, or code. In some instances, the system may supplement and/or replace the operator with machine learning engines that act on the developed insights.

Abstract: Disclosed herein are embodiments of a combination and/or composition comprising a Bacillus composition comprising three or four direct fed microbial (DFMs) selected from Bacillus coagulans, Bacillus subtilis, Bacillus licheniformis and Bacillus amyloliquefaciens, and an essential oil composition, and optionally may further comprise yucca and/or quillaja, such as Yucca schidigera and/or Quillaja saponaria. The essential oil composition may comprise oregano essential oil. Also disclosed are embodiments of a feed composition comprising the disclosed combination and/or composition and a feed. Also methods for administering the combination and/or composition to a non-ruminant animal, particularly an avian, are disclosed. The combination and/or composition may provide a beneficial effect to the animal upon administration, such as, but not limited to, weight gain, feed conversion, and/or reducing bacterial load.

Abstract: Embodiments of a composition and/or combination comprising an anionic dietary supplement and 25-hydroxy vitamin D are disclosed. The anionic dietary supplement may be a negative dietary cation anion difference (DCAD) supplement and/or may comprise magnesium chloride, magnesium sulfate, ammonium chloride, ammonium sulfate, and calcium sulfate, and/or complexes thereof. Also disclosed are embodiments of a method for administrating the combination and/or composition to an animal, such as a ruminant. In certain embodiments, the animal is a dairy cow, and the method may be a method for increasing milk yield, and/or improving the health of the animal.

Abstract: Pulse dosing is used to administer a cleaning formulation into a fluid process stream flowing through structural components of a processing facility. The fluid process stream may contain corn, corn-derived products, or a combination thereof, or the fluid process stream may contain a process condensate, a rinse fluid, a cleaning fluid or any combination thereof. The processing facility may be an ethanol processing plant, a protein processing plant, a corn oil processing plant, an ethanol and corn oil processing plant, an ethanol and protein processing plant, or an ethanol, corn oil and protein processing plant. Pulse dosing may include administering the cleaning formulation into the fluid process stream for a period of x seconds every y minutes, with no administration of the cleaning formulation between the periods of x seconds.

Abstract: Vaccine formulations comprising polyglycerol polyricinoleate (PGPR) are disclosed. Certain disclosed exemplary vaccine formulations comprised an aqueous phase comprising inactivated bacteria and/or viruses, and/or bacterial and/or viral antigens. One particular embodiment comprised an inactivated H9N2 PGPR emulsion-based vaccine for day-old chicks. Disclosed PGPR-based vaccine formulations can be administered alone, or in combination with or as a composition including a second standard fast release vaccine. Disclosed vaccines delay antigen release, and therefore delay an immune response in a subject receiving the vaccine, typically by 7-35 days. The present invention also concerns a method for vaccinating a subject, such as poultry or fish, with disclosed vaccine formulations, as well as a method for making PGPR-based vaccine formulations.

Abstract: Disclosed embodiments concern concentrated compositions comprising a microbial suspension and a preservative system, such as a paraben preservative, an isothiazolinone preservative, and a quaternary ammonium preservative. Microbes used to form the compositions generally are spore-forming microbes, such as bacteria or fungi, with representative embodiments concerning compositions comprising Bacillus. Concentrated compositions may be formulated by combining a Prep A composition comprising a microbial suspension with a Prep B composition comprising a preservative system. Preserved concentrated microbial compositions may be formulated at any of various concentrations relative to diluted, ready-to-use compositions, such as 40×, 50×, 80×, 100× and 250× compositions. Diluted microbial suspension compositions can be used as a cleaning product, an odor control aid, as a janitorial product, as an agricultural product, as a product to treat wastewater, as an environmental product, or as a processing aid.

Abstract: Pulse dosing is used to administer a cleaning formulation into a fluid process stream flowing through structural components of a processing facility. The fluid process stream may contain corn, corn-derived products, or a combination thereof, or the fluid process stream may contain a process condensate, a rinse fluid, a cleaning fluid or any combination thereof. The processing facility may be an ethanol processing plant, a protein processing plant, a corn oil processing plant, an ethanol and corn oil processing plant, an ethanol and protein processing plant, or an ethanol, corn oil and protein processing plant. Pulse dosing may include administering the cleaning formulation into the fluid process stream for a period of x seconds every y minutes, with no administration of the cleaning formulation between the periods of x seconds.

Abstract: Methods, systems, and apparatuses to improve the handling of exceptions during the retrieval and processing of health records from various data sources are provided. During the retrieval and processing of health records, exceptions to typical behavior are recorded with context at the data extraction protocol level, at the health record level and at the level of elements with the document. Accordingly, insights may be developed and configurations, rules, or coding changes, based on the detected exceptions may be proposed. In some instances, an operator may be notified about the exceptions such that the operator may act on the insight. In some instances, the processing of extracted records (documents, messages) may be deferred until the operator has made appropriate changes to configuration, rules, or code. In some instances, the system may supplement and/or replace the operator with machine learning engines that act on the developed insights.

Abstract: Disclosed compositions comprise a therapeutic agent and a carrier selected, or processed to have, an acceptable composite flow index, a granular particle size of 18 mesh to 80 mesh, or both, such as processed granular wheat middlings. The composition may also comprise an oil and/or micro tracers. Suitable granular wheat middlings may have a size range of from 18 mesh to 80 mesh, such as 20 mesh to 80 mesh. The composition has improved flowability characteristics, compared to a composition where the carrier, such as processed wheat middlings, are powdered and/or flakey. Certain embodiments concern a composition comprising, consisting essentially of, or consisting of, nicarbazin, granular wheat middlings, soybean oil and micro tracers. The composition may be administered to an animal, for example, to treat or prevent coccidiosis. Also disclosed herein are methods for making and using the composition.

Abstract: A method for modulating an immune response by activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA) is provided. Modulation is achieved by modulating the activity, the abundance or both of: a natural killer cell, a CD8 T-cell, a CD4 T-cell, a B-cell, a dendritic cell, a macrophage, a granulocyte, or their combination.

Abstract: Inactivated antigens have only been used in avian medicine in parenterally administered vaccines. The only mucosally administered vaccines have been live, modified live, or attenuated vaccines. However, live vaccines have several disadvantages, including the risk of causing disease. Disclosed embodiments concern a composition comprising inactivated bacterial and/or viral antigens that is formulated for mucosal administration to an avian, and a method of using the composition. In certain embodiments, the composition comprises inactivated Clostridium perfringens type A antigens, and/or Salmonella spp. antigens, such as antigens from Salmonella kentucky, Salmonella typhimurium, and/or Salmonella enteriditis, or E. coli antigens. The composition may comprise a polyacrylic acid adjuvant. The composition may be administered to an avian in ovo, during the first 14 days after hatching, or after the first 14 days.

Abstract: Peptides predicted to be immunogenic against African swine fever virus (ASFV) and vaccine compositions that include the peptides are disclosed herein. In some embodiments, these compositions comprise or consist of one or more peptides comprising the amino acid sequence set forth in SEQ ID NOs: 2-2273. In other embodiments, the compositions comprise viral vectors or host cells, or combinations thereof, that comprise one or more of the peptides. In other embodiments, the compositions comprise nucleic acid molecules comprising one or more of the peptides. The compositions disclosed can include one or more additional components, such as, but not limited to, a carrier, an adjuvant, an additional therapeutic, or combinations thereof. Containers and kits that comprise the compositions are described. Uses of the compositions can include administration to an animal to induce an immune response in the animal, or to immunize the animal against ASFV.

Abstract: Pulse dosing is used to administer a cleaning formulation into a fluid process stream flowing through structural components of a processing facility. The fluid process stream may contain corn, corn-derived products, or a combination thereof, or the fluid process stream may contain a process condensate, a rinse fluid, a cleaning fluid or any combination thereof. The processing facility may be an ethanol processing plant, a protein processing plant, a corn oil processing plant, an ethanol and corn oil processing plant, an ethanol and protein processing plant, or an ethanol, corn oil and protein processing plant. Pulse dosing may include administering the cleaning formulation into the fluid process stream for a period of x seconds every y minutes, with no administration of the cleaning formulation between the periods of x seconds.

Abstract: The majority of the mortality observed in young pigs occurs between three and five weeks post-weaning for S. suis infections and between four and six weeks post-weaning for H. parasuis and Actinobacillus suis infections. Clinical disease control associated with S. suis, A. suis and H. parasuis has been attempted using antibiotic treatment, by controlled exposure with live organisms, and by vaccination, using either inactivated commercial or autogenous bacterins administered parenterally. A similar lack of protection in very young pigs is observed with various viruses including swine influenza virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus and rotavirus. Disclosed herein is an immunogenic composition comprising inactivated antigens and a mucosal adjuvant.

Abstract: Disclosed herein are embodiments of a combination and/or composition for administration to animals. In some embodiments, the combination and/or composition can be administered to treat and/or prevent a disease in animals. In some embodiments, the combination and/or composition can be administered to promote animal health. In some embodiments, the combination comprises a composition comprising Yucca schidigera, Quillaja saponaria, and combinations thereof and a composition comprising an antimicrobial, an antibiotic, an anticoccidial, a vaccine, or combinations thereof. The combinations or compositions disclosed herein can also improve feed conversion rates in animals.

Abstract: A scaffold is provided, the scaffold comprising: at least one inlet tube; at least one outlet tube; and a plurality of porous elongated microtubes, wherein each one of said porous elongated microtube has an inner diameter of 5-100 micrometers, wherein said plurality of elongated microtubes extend from said at least one inlet tube to said at least one outlet tube and is in fluid communication thereto, Further provided is a method for producing and using the scaffold, such as for tissue engineering.

Abstract: The majority of the mortality observed in young pigs occurs between three and five weeks post-weaning for S. suis infections and between four and six weeks post-weaning for H. parasuis and Actinobacillus suis infections. Clinical disease control associated with S. suis, A. suis and H. parasuis has been attempted using antibiotic treatment, by controlled exposure with live organisms, and by vaccination, using either inactivated commercial or autogenous bacterins administered parenterally. A similar lack of protection in very young pigs is observed with various viruses including swine influenza virus, porcine reproductive and respiratory syndrome virus, porcine epidemic diarrhea virus and rotavirus. Disclosed herein is an immunogenic composition comprising inactivated antigens and a mucosal adjuvant.

Abstract: Disclosed herein are embodiments of a combination and/or composition for administration to animals. In some embodiments, the combination and/or composition can be administered to treat and/or prevent a disease in animals. In some embodiments, the combination and/or composition can be administered to promote animal health. In some embodiments, the combination comprises a composition comprising Yucca schidigera, Quillaja saponaria, and combinations thereof and a composition comprising an antimicrobial, an antibiotic, an anticoccidial, a vaccine, or combinations thereof. The combinations or compositions disclosed herein can also improve feed conversion rates in animals.

Abstract: A method including sensing local accelerations or changes in sensor position, including orientation and displacement, with a local acceleration sensor mounted on a chest or abdomen of a patient, and calculating energy of polyphasic motions, based on sensed information of the local acceleration sensor and classifying severity of cardiac decompensation by calculating an excessive energy index (EEi) that compares excessive energy that appears in the polyphasic motions to energy required for inspiration at a basic respiratory rate.

Abstract: A composition useful for application to plants, seeds or soil to inhibit fungal infections comprising a protein source inoculated with from 5×107 cfu to 5×109 cfu of a Bacillus amyloliquefaciens strain per gram of the protein source.